SCHEMBL24492827

SCHEMBL24492827

c1ccc(-n2c3ccccc3c3cc(-c4cc(-c5cccc(-c6cncc(-c7ccncc7)c6)c5)cc(-c5cccc(-c6cncc(-c7ccncc7)c6)c5)c4)ccc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MKNK1 Q9BUB5 2/20 0.40
▸ MAPT P10636 3/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PIK3CA P42336 2/20 0.39
▸ NOTUM Q6P988 1/20 0.38
▸ CYP11B1 P15538 2/20 0.36
▸ CYP11B2 P19099 2/20 0.36
▸ TSPO P30536 1/20 0.36
▸ MKNK2 Q9HBH9 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ IMPDH2 P12268 1/20 0.36
▸ PRKCI P41743 1/20 0.35
▸ KIF11 P52732 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ HTR6 P50406 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24493056 0.95 KDM4E (0.50) KDM4EATML3MBTL1MKNK1MAPT
SCHEMBL24492873 0.91 MKNK1 (0.39) MKNK1MAPTMEN1HSP90AA1KMT2A
SCHEMBL24492826 0.90 KDM4E (0.45) KDM4EATML3MBTL1MKNK1MAPT
SCHEMBL22252920 0.90 L3MBTL1 (0.45) KDM4EATML3MBTL1MKNK1MAPT
SCHEMBL11987839 0.90 L3MBTL1 (0.47) KDM4EATML3MBTL1MKNK1MAPT
SCHEMBL11981064 0.90 L3MBTL1 (0.53) KDM4EATML3MBTL1MKNK1MAPT
SCHEMBL11987828 0.90 L3MBTL1 (0.49) KDM4EATML3MBTL1MKNK1MAPT
SCHEMBL19933769 0.89 KDM4E (0.56) KDM4EATML3MBTL1MKNK1MAPT
SCHEMBL24492899 0.89 ATM (0.46) KDM4EATML3MBTL1MKNK1MAPT
SCHEMBL24526113 0.88 KDM4E (0.49) KDM4EATML3MBTL1MKNK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT ETV6, LEF1, TEAD2 KDM4E 688/4885ATM 3566/4885L3MBTL1 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback